Decreasing cardiac chamber sizes and associated heart dysfunction in COPD: role of hyperinflation

Henrik Watz1, Benjamin Waschki, Trhorsten Meyer

  • 1Pulmonary Research Institute, Hospital Grosshansdorf, Center for Pneumology and Thoracic Surgery, Woehrendamm 80, D-22927 Grosshansdorf, Germany. h.watz@pulmoresearch.de

Chest
|March 2, 2010
PubMed

Insights

Chronic obstructive pulmonary disease (COPD) severity is linked to smaller heart size and dysfunction. Lung hyperinflation, specifically inspiratory-to-total lung capacity ratio, significantly impacts heart size and function, affecting exercise capacity.

Area of Science:

  • Cardiology
  • Pulmonology
  • Medical Imaging

Background:

  • The relationship between abnormal lung function and cardiac structure/function in COPD patients is poorly understood.
  • Investigating these links is crucial for understanding COPD progression and its systemic effects.

Purpose of the Study:

  • To examine the association between lung function parameters and cardiac chamber sizes in COPD patients.
  • To determine the impact of lung function on cardiac dysfunction and its relation to exercise capacity (6-min walk distance).

Main Methods:

  • Echocardiography was used to assess cardiac chamber sizes and ventricular dysfunction (left ventricular diastolic and right ventricular Tei-index) in 138 COPD patients (GOLD I-IV).
  • Lung function was evaluated using spirometry, body plethysmography, and diffusion capacity.
  • The 6-min walk distance (6MWD) was measured.

Main Results:

  • Cardiac chamber sizes decreased with increasing COPD severity (GOLD stage).
  • Static hyperinflation, particularly the inspiratory-to-total lung capacity ratio (IC/TLC), showed stronger correlations with cardiac chamber sizes than airway obstruction or diffusion capacity.
  • An impaired left ventricular diastolic filling pattern and right ventricular dysfunction (Tei-index) were observed in patients with lower IC/TLC (< or = 0.25), and this diastolic dysfunction was linked to reduced 6MWD.

Conclusions:

  • COPD severity correlates with reduced heart size.
  • Lung hyperinflation, especially reduced IC/TLC, appears to be a significant factor in cardiac remodeling and dysfunction in COPD patients.
  • Impaired left ventricular diastolic function is independently associated with decreased exercise capacity in COPD.
Abstract

Related Concept Videos

Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Chronic Obstructive Pulmonary Disease II: Emphysema01:23

Chronic Obstructive Pulmonary Disease II: Emphysema

Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...